A short post from Hany Ragy on trypanophobia and the pill form of Wegovy, linking out for more on why needle-averse patients may lean toward oral semaglutide.
Recap by typeshit. Post by Hany Ragy on X.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
Presented at EASD 2026, the 52-week analysis showed a 1.46 point bigger weight drop. A GlobalData analyst says head-to-head trials are still needed.
Reuters reports the Hyderabad drugmaker expanded its generic semaglutide lineup to cover a supply-chain problem with its original Obeda brand.
Loading…